Provider
QP2R1-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Program effective Date: Jun 23, 2021
Documents & Forms Results
Displaying 2131 - 2140 of 3159 results
Provider
QP50-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective August 1, 2021
Program effective Date: Jun 09, 2021
Provider
QP51-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 25, 2021
Program effective Date: Jun 09, 2021
Provider
QP47-21 Audio-Only Telehealth Visits do not Meet Requirements for Risk Adjustment Face-to-Face Requirement
Program effective Date: Jun 09, 2021
Provider
QP49-21 Update for New to Market Medical Drugs: Anifrolumab, Teplizumab, Donislecel, and Difelikefalin
Program effective Date: Jun 09, 2021
Provider
QP48-21 Learn to Live – An Online Behavioral Health Resource for Select Blue Cross and Blue Shield of Minnesota Health Plan Members
Program effective Date: Jun 09, 2021
Provider
P35-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Jun 01, 2021
Provider
P33-21 Change to Medical Review Process for Outpatient Therapies Services
Program effective Date: Jun 01, 2021
Provider
P36-21 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update
Program effective Date: Jun 01, 2021
Provider
P34-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 2, 2021
Program effective Date: Jun 01, 2021